Optical News

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the third quarter ended October 2, 2026. The Company will host an earnings call and webcast today at 5:30 PM Eastern Time. Third Quarter and Year-to-Date 2026 Highlights Include: Net sales down 12% Y/Y; up 21% excluding a 33-percentage point ($25.9...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported financial results and recent business updates for the third quarter ended September 30, 2026. "We are highly encouraged by the strength of Lumvoa's early launch in TED, which has exceeded expectations," said Steve Mahoney, President and Chief Executive Offi...

KOFU, Japan--(BUSINESS WIRE)--The XXI edition of Fujio Cup Quiz (FCQ) in NCRM NICHE 2026, hosted by GN Corporation, Japan and Nichi-In centre for Regenerative Medicine (NCRM), was won by Sameer Kumar Reddy and Chava Aravind Kumar from Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, India. Ganga Anand Desai and Amith Mathew from Sri Ramachandra Institute of Higher Education and Research, Chennai, India, came runners. International regenerative medicine event, NCRM NICHE, hos...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Bio, a clinical-stage biotechnology company developing new medicines for vision-threatening diseases, will present at investor conferences....

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:Stifel Healthcare Conference on Tuesday, November 10, 2026, at 8:40 a.m. ET in New York City, NYJefferies Global Healthcare Conference on Wednesday, November...

MIDDLETOWN, Pa.--(BUSINESS WIRE)--OpZira™, Inc., an ophthalmic medical device company advancing technologies for the detection and monitoring of ocular disease, today announced its selection to present at the 2026 New York Venture Summit, taking place November 18-19 at the Javits Center in New York City.Hosted by youngStartup Ventures, the summit will feature 200 innovative companies selected to present their technologies and growth opportunities to an audience of venture capital firms, corporat...

ANNAPOLIS, Md.--(BUSINESS WIRE)--Vision Innovation Partners ("VIP"), a leading Mid-Atlantic eye care platform, today announced the opening of a new ambulatory surgery center ("ASC") in Frederick, Maryland. The new center will provide patients with expanded access to specialized ophthalmic surgical services. The Maryland Vision Institute Surgical Center is dedicated exclusively to outpatient eye surgery, offering a range of procedures including cataract and lens implant surgery, refractive surge...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--PHIL Inc., the technology-powered patient access platform, today announced its partnership with Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, to launch HarrowRx, Harrow’s new prescribing and access platform. HarrowRx gives eye care providers the ability to e-prescribe Harrow’s branded ophthalmic portfolio from one destination within the electronic medical record (EMR) systems they already use, with built...

MIDDLETOWN, Pa.--(BUSINESS WIRE)--OpZira™, Inc., an ophthalmic medical device company advancing technologies for the detection and monitoring of ocular disease, today announced its subsidiary, AdaptDx, Inc., has completed its Stage II audit at the company's Lighthouse medical device manufacturing facility. The audit represents an important step in the ISO certification process and supports OpZira's plans to pursue CE marking for AdaptDx Pro® in the European Union in 2027.AdaptDx Pro is a portabl...

LOS ANGELES--(BUSINESS WIRE)--The University Eye Center Los Angeles, part of Ketchum Health, the clinical teaching facility of Marshall B. Ketchum University (MBKU), is partnering with Walgreens to offer free flu shots to uninsured and underinsured Los Angeles residents at three clinics this November, giving patients time to build protection before the holidays. The clinics are aimed at the Angelenos most likely to go without a flu shot. About 1 in 12 Los Angeles County residents had no health...